First Quarter 2018 Financial Results Announced

For the first quarter ended March 31, 2018, the Company reported revenue of $7.1 million compared to $5.2 million for the first quarter 2017. Net income was $0.8 million, or $0.07 per diluted share, compared to a net loss of $(0.2) million, or $(0.02) per share for the first quarter 2017.

Read More
Kevin Jirka
2017 Fourth Quarter Financial Results Conference Call

 IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 fourth quarter financial results before the market opens on Tuesday, February 6th.  IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. 

Read More
Kevin Jirka
2018 Annual and First Quarter Financial Guidance

Winter Springs, Florida, January 22, 2018 – IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (MRI) medical devices and the only known provider of a non-magnetic intravenous (IV) infusion pump system that is designed to be safe for use during MRI procedures, today announced its financial guidance for the full year and first quarter 2018. 

Read More
Kevin Jirka